Bo Qin

Dr. Bo Qin


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Drug Resistance Updates
Verified
Journal Article
Closed access
ZSZhenwei Su
Zhenwei Su
SDShaowei Dong
Shaowei Dong
SZShan-Chao Zhao
Shan-Chao Zhao
KLKaisheng Liu
Kaisheng Liu
YTYao Tan
Yao Tan
CZChang Zou
Chang Zou

3 March 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
RYRunzhu Yuan
Runzhu Yuan
YTYao Tan
Yao Tan
PSPing-Hui Sun
Ping-Hui Sun
BQBo Qin
Bo Qin
ZLZhen Liang
Zhen Liang
Background: Cancer, also known as a malignant tumor, is caused by the activation of oncogenes, which leads to the uncontrolled proliferation of cells that results in swelling. According to the World Health Organization (WHO), cancer is one of the main causes of death worldwide. The main variables limiting the efficacy of anti-tumor treatments are side effects and drug resistance. The search for natural, safe, low toxicity, and efficient chemical compounds in tumor research is essential. Berberine is a pentacyclic isoquinoline quaternary ammonium alkaloid isolated from Berberis and Coptis that has long been used in clinical settings. Studies in recent years have reported the use of berberine in cancer treatment. In this study, we performed a bibliometric analysis of berberine- and tumor-related research.Materials and methods: Relevant articles from January 1, 2002, to December 31, 2021, were identified from the Web of Science Core Collection (WOSCC) of Clarivate Analytics. Microsoft Excel, CiteSpace, VOSviewer, and an online platform were used for the literary metrology analysis.Results: A total of 1368 publications had unique characteristics. Publications from China were the most common (783 articles), and Y. B. Feng (from China) was the most productive author, with the highest total citations. China Medical University (Taiwan) and Sun Yat-sen University (China) were the two organizations with the largest numbers of publications (36 each). Frontiers in Pharmacology was the most commonly occurring journal (29 articles). The present body of research is focused on the mechanism, molecular docking, and oxidative stress of berberine in tumors.Conclusion: Research on berberine and tumors was thoroughly reviewed using knowledge map and bibliometric methods. The results of this study reveal the dynamic evolution of berberine and tumor research and provide a basis for strategic planning in cancer research.

1 January 2020 in International Journal of Biological Sciences
Verified
Journal Article
Open access
DLDan Li
Dan Li
SXShixin Xiang
Shixin Xiang
JSJing Shen
Jing Shen
MXMingtao Xiao
Mingtao Xiao
YZYueshui Zhao
Yueshui Zhao
QWQinglian Wen
Qinglian Wen
Objectives: B7 family members were identified as co-stimulators or co-inhibitors of the immune response and played important roles in cancer immunotherapy; however, their dysregulation in gastric cancer is still unclear.

29 January 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZXZhenyu Xu
Zhenyu Xu
YXYabin Xia
Yabin Xia
ZXZhangang Xiao
Zhangang Xiao
YJYuliang Jia
Yuliang Jia
LLLina Li
Lina Li
JSJing Shen
Jing Shen
Histone methylation is thought to control the regulation of genetic program and the dysregulation of it has been found to be closely associated with cancer. JMJD3 has been identified as an H3K27 demethylase and its role in cancer development is context specific. The role of JMJD3 in gastric cancer (GC) has not been examined. In this study, JMJD3 expression was determined. The prognostic significance of JMJD3 and its association with clinical parameters were evaluated. JMJD3 dysregulation mechanism and targets were analyzed. The effect of JMJD3 mutation was determined by functional study. Results showed that JMJD3 was overexpressed in different patient cohorts and also by bioinformatics analysis. High JMJD3 expression was correlated with shortened overall survival in patients with GC and was an independent prognosis predictor. Genetic aberration and DNA methylation might be involved in the deregulation of JMJD3 in GC. Downstream network of JMJD3 was analyzed and several novel potential targets were identified. Furthermore, functional study discovered that both demethylase-dependent and demethylase-independent mechanisms were involved in the oncogenic role of JMJD3 in GC. Importantly, histone demethylase inhibitor GSK-J4 could reverse the oncogenic effect of JMJD3 overexpression. In conclusion, our study report the oncogenic role of JMJD3 in GC for the first time. JMJD3 might serve as an important epigenetic therapeutic target and/or prognostic predictor in GC.

16 February 2024 in Drug Discovery Today
Verified
Journal Article
Closed access
DLDongcheng Liu
Dongcheng Liu
ZLZiling Liu
Ziling Liu
HLHongxia Liao
Hongxia Liao
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen
BQBo Qin
Bo Qin

7 February 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
KLKe Liu
Ke Liu
CZChang Zou
Chang Zou
BQBo Qin
Bo Qin
Nuclear hormone receptors (NRs) are one of the most abundant transcription factors in the human cells. They regulate expression of genes via interactions with corresponding ligands, co-activators, and co-repressors. These molecular pathways play important roles in the development, cell differentiation, and physiologic and metabolic processes. Increasingly, targeting nuclear receptors is becoming a promising strategy for new drug development. The aim of this review is to discuss the association between nuclear receptors and eye development, and expand their role in various ocular diseases such as keratitis, cataract, glaucoma, uveitis, retinopathy, and ophthalmic tumors. Recent studies in this area are highlighted as well as future research directions and potential clinical applications. Finally, various strategies will be elucidated to inspire more targeted therapies for ocular diseases through the use of nuclear receptors.